Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The implications of stochastic synthesis for the conjugation of functional groups to nanoparticles.

Mullen DG, Desai AM, Waddell JN, Cheng XM, Kelly CV, McNerny DQ, Majoros IJ, Baker JR Jr, Sander LM, Orr BG, Banaszak Holl MM.

Bioconjug Chem. 2008 Sep;19(9):1748-52. doi: 10.1021/bc8002106. Epub 2008 Aug 26.

2.

A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Mullen DG, Fang M, Desai A, Baker JR, Orr BG, Banaszak Holl MM.

ACS Nano. 2010 Feb 23;4(2):657-70. doi: 10.1021/nn900999c.

3.

Synthesis of nanoparticle-cored dendrimers by convergent dendritic functionalization of monolayer-protected nanoparticles.

Shon YS, Choi D, Dare J, Dinh T.

Langmuir. 2008 Jun 1;24(13):6924-31. doi: 10.1021/la800759n. Epub 2008 May 29.

PMID:
18507425
4.

PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Majoros IJ, Myc A, Thomas T, Mehta CB, Baker JR Jr.

Biomacromolecules. 2006 Feb;7(2):572-9.

PMID:
16471932
5.

Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles.

Gaertner HF, Cerini F, Kamath A, Rochat AF, Siegrist CA, Menin L, Hartley O.

Bioconjug Chem. 2011 Jun 15;22(6):1103-14. doi: 10.1021/bc1005653. Epub 2011 May 31.

PMID:
21574642
6.

Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Mullen DG, Banaszak Holl MM.

Acc Chem Res. 2011 Nov 15;44(11):1135-45. doi: 10.1021/ar1001389. Epub 2011 Aug 3.

7.

Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.

Majoros IJ, Thomas TP, Mehta CB, Baker JR Jr.

J Med Chem. 2005 Sep 22;48(19):5892-9.

PMID:
16161993
8.

Isolation and characterization of dendrimers with precise numbers of functional groups.

Mullen DG, Borgmeier EL, Desai AM, van Dongen MA, Barash M, Cheng XM, Baker JR Jr, Banaszak Holl MM.

Chemistry. 2010 Sep 17;16(35):10675-8. doi: 10.1002/chem.201001175. No abstract available.

9.

Coordination and reduction processes in the synthesis of dendrimer-encapsulated Pt nanoparticles.

Yamamoto D, Watanabe S, Miyahara MT.

Langmuir. 2010 Feb 16;26(4):2339-45. doi: 10.1021/la902770p.

PMID:
20141201
10.

Evaluating binding avidities of populations of heterogeneous multivalent ligand-functionalized nanoparticles.

Li MH, Choi SK, Leroueil PR, Baker JR Jr.

ACS Nano. 2014 Jun 24;8(6):5600-9. doi: 10.1021/nn406455s. Epub 2014 May 13.

PMID:
24810868
11.

Encapsulation of acetylshikonin by polyamidoamine dendrimers for preparing prominent nanoparticles.

Peng J, Zhou W, Xia X, Qi X, Sun L, Wang M, Wu Z, Li Z.

AAPS PharmSciTech. 2014 Apr;15(2):425-33. doi: 10.1208/s12249-014-0074-2. Epub 2014 Jan 22.

12.

Resolving the structure of ligands bound to the surface of superparamagnetic iron oxide nanoparticles by high-resolution magic-angle spinning NMR spectroscopy.

Polito L, Colombo M, Monti D, Melato S, Caneva E, Prosperi D.

J Am Chem Soc. 2008 Sep 24;130(38):12712-24. doi: 10.1021/ja802479n. Epub 2008 Aug 30.

PMID:
18761445
13.

Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity.

Strydom SJ, Rose WE, Otto DP, Liebenberg W, de Villiers MM.

Nanomedicine. 2013 Jan;9(1):85-93. doi: 10.1016/j.nano.2012.03.006. Epub 2012 Mar 30.

PMID:
22470054
14.

Hybrid gold-nanoparticle-cored conjugated thiophene dendrimers: synthesis, characterization, and energy-transfer studies.

Deng S, Fulghum TM, Krueger G, Patton D, Park JY, Advincula RC.

Chemistry. 2011 Aug 1;17(32):8929-40. doi: 10.1002/chem.201100246. Epub 2011 Jun 28.

PMID:
21714015
15.

Synthesis, characterization, and applications of dendrimer-encapsulated nanoparticles.

Scott RW, Wilson OM, Crooks RM.

J Phys Chem B. 2005 Jan 20;109(2):692-704.

PMID:
16866429
16.

Modification of multi-wall carbon nanotube surfaces with poly(amidoamine) dendrons: synthesis and metal templating.

Tao L, Chen G, Mantovani G, York S, Haddleton DM.

Chem Commun (Camb). 2006 Dec 21;(47):4949-51. Epub 2006 Oct 9.

PMID:
17136257
17.

Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.

Kirkpatrick GJ, Plumb JA, Sutcliffe OB, Flint DJ, Wheate NJ.

J Inorg Biochem. 2011 Sep;105(9):1115-22. doi: 10.1016/j.jinorgbio.2011.05.017. Epub 2011 May 27.

PMID:
21704583
18.

Synthesis and evaluation of pegylated dendrimeric nanocarrier for pulmonary delivery of low molecular weight heparin.

Bai S, Ahsan F.

Pharm Res. 2009 Mar;26(3):539-48. doi: 10.1007/s11095-008-9769-y. Epub 2008 Nov 25.

PMID:
19034631
19.

HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups.

Islam MT, Shi X, Balogh L, Baker JR Jr.

Anal Chem. 2005 Apr 1;77(7):2063-70.

PMID:
15801739
20.

Synthesis of dendritic stationary phases with surface-bonded L-phenylalanine derivate as chiral selector and their evaluation in HPLC resolution of racemic compounds.

Yin CQ, He BJ, Huang SH, Zhang JY, Bai ZW, Li ZY.

Chirality. 2008 Jul;20(7):846-55. doi: 10.1002/chir.20555.

PMID:
18381735

Supplemental Content

Support Center